Joby Aviation agreed on August 4, 2025 to buy Blade Air Mobility's passenger business for up to $125 million, and Blade's medical division, which flies human organs for transplant, will stay a separate public company named Strata Critical Medical, Joby announced.
The detail that matters for hospitals: Joby becomes Strata's preferred partner for electric vertical takeoff and landing (eVTOL) aircraft wherever Joby operates, putting organ transport on the list of early uses for electric air taxis.
The deal
- Joby pays up to $125 million in cash or stock for Blade's passenger business, which flew more than 50,000 passengers in 2024 from 12 urban terminals, including JFK and Newark.
- Blade's medical division was excluded and was renamed Strata Critical Medical, Air Med & Rescue reported.
- Blade founder Rob Wiesenthal leads Blade as a Joby subsidiary and serves as non-executive chairman of Strata, Axios reported.
- Blade's chief financial officer, William Heyburn, and president, Melissa Tomkiel, became co-CEOs of Strata, according to Axios.
- Joby said Blade's passenger flights would continue as normal, and that it planned to carry its first passengers in Dubai in 2026.
Electric air taxis like Joby's take off and land vertically like helicopters but run on batteries. Joby's plan is to move Blade's existing customers gradually from conventional helicopters to its own aircraft, using Blade's terminals instead of building its own.
Why organ transport is a test case
Donor organs are flown under tight time limits, and transplant teams already rely on helicopters and planes to move them. A June 2025 federal executive order also called for eVTOL pilot projects that include medical response, Axios reported. Whether electric aircraft improve transplant logistics in practice has yet to be shown. Range, weather limits, landing sites at hospitals and certification by aviation regulators will all decide how quickly these aircraft can carry anything as critical as a donor heart or kidney.
What it means for students and residents
- Transplant logistics are clinical. Ischemic time affects outcomes, so how organs move is part of transplant medicine.
- Watch for evidence, not announcements. The question is whether eVTOL flights shorten transport times and improve graft outcomes in real programs. More in MedRise Medical News; meet transplant and aerospace physicians at events on our conference list.
The aircraft are coming. The data on patient benefit will take longer.
MedRise Medical News summarizes public announcements and research for education only. It is not medical, legal or immigration advice.

